These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15743540)

  • 1. Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1.
    Karavasilis V; Malamou-Mitsi V; Briasoulis E; Tsanou E; Kitsou E; Kalofonos H; Fountzilas G; Fotsis T; Pavlidis N
    BMC Cancer; 2005 Mar; 5():25. PubMed ID: 15743540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma.
    Karavasilis V; Malamou-Mitsi V; Briasoulis E; Tsanou E; Kitsou E; Pavlidis N
    Int J Gynecol Cancer; 2006; 16 Suppl 1():241-6. PubMed ID: 16515598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
    Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M
    Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
    Donmez G; Sullu Y; Baris S; Yildiz L; Aydin O; Karagoz F; Kandemir B
    Pathol Res Pract; 2009; 205(12):854-7. PubMed ID: 19762163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
    Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
    BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
    Kaio E; Tanaka S; Oka S; Hiyama T; Kitadai Y; Haruma K; Chayama K
    Int J Oncol; 2003 Oct; 23(4):901-11. PubMed ID: 12963968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
    Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
    Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
    Ohta Y; Shridhar V; Kalemkerian GP; Bright RK; Watanabe Y; Pass HI
    Cancer; 1999 Jun; 85(12):2570-6. PubMed ID: 10375104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
    Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
    Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
    Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
    Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
    Netto GC; Bleil CB; Hilbig A; Coutinho LM
    Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1.
    Aspiotis M; Tsanou E; Gorezis S; Ioachim E; Skyrlas A; Stefaniotou M; Malamou-Mitsi V
    Eye (Lond); 2007 Aug; 21(8):1095-101. PubMed ID: 16823458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density and VEGF, HIF-1α expression in primary oral melanoma: correlation with prognosis.
    Simonetti O; Lucarini G; Rubini C; Goteri G; Zizzi A; Staibano S; Campanati A; Ganzetti G; Di Primio R; Offidani A
    Oral Dis; 2013 Sep; 19(6):620-7. PubMed ID: 23279259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-1 expression in breast cancer: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
    Ioachim E; Damala K; Tsanou E; Briasoulis E; Papadiotis E; Mitselou A; Charhanti A; Doukas M; Lampri L; Arvanitis DL
    Histol Histopathol; 2012 Feb; 27(2):209-16. PubMed ID: 22207555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.